TrialScientific reports2018

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

T P MacGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.